Real-world clinical practice in health technology assessment: state of the art for 2022-Reference-Cited by-同舟云学术

Real-world clinical practice in health technology assessment: state of the art for 2022

Published:2023-01-24 Issue:4 Volume:2 Page:1-9
ISSN:2782-3784
Container-title:Real-World Data & Evidence
language:
Short-container-title:MyRWD

Author:

Kurylev A. A.¹^ORCID,Zhuravkov A. A.²^ORCID,Kolbin A. S.³^ORCID

Affiliation:

1. First St. Petersburg State Medical University, named after I.P. Pavlov; Federal State Budgetary Institution «National Medical Research Center of Oncology named after N.N. Petrov»

2. First St. Petersburg State Medical University, named after I. P. Pavlov; St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncology)

3. First St. Petersburg State Medical University, named after I. P. Pavlov; St. Petersburg State University

Abstract

The real-world data are used in drug authorization procedures, comparative efficacy and safety research, to make changes in the Summary of Product Characteristics, clinical recommendations. One more aspect where RWD/RWE can be used is the health technology assessment. Although there is a clear need for high-quality recommendations regarding RWE studies, published today documents do not contain clear instructions.

Publisher

Publishing House OKI

Reference23 articles.

1. Woolery LK, & Grzymala-Busse JW (1994). Research Paper: Machine Learning for an Expert System to Predict Preterm Birth Risk. Journal of the American Medical Informatics Association: JAMIA. 1994;1 (6):439‑46.

2. Grootendorst DC, Jager KJ, Zoccali C, Dekker FW. Observational studies are complementary to randomized controlled trials. Nephron Clin Pract. 2010;114 (3):c173–7. doi: 10.1159 / 000262299. Epub 2009 Nov 28. PMID: 19955822.

3. Makady A, de Boer A, Hillege H, Klungel O, Goettsch W; (on behalf of GetReal Work Package 1). What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews. Value Health. 2017 Jul-Aug;20 (7):858‑65. doi: 10.1016 / j. jval. 2017.03.008. Epub 2017 May 11. PMID: 28712614.

4. Reshenie Soveta Evrazijskoj ekonomicheskoj komissii ot 17 marta 2022 g. N 36 «O vnesenii izmenenij v Pravila registracii i ekspertizy lekarstvennyh sredstv dlya medicinskogo primeneniya». (In Russ.).

5. Исследования реальной клинической практики / А. С. Колбин, Д. Ю. Белоусов, С. К. Зырянов, В. В. Омельяновский, Д. А. Сычёв, А. Л. Хохлов, С. Л. Плавинский, Б. К. Романов, М. В. Журавлёва, Е. В. Вербицкая, Е. А. Вольская, Д. А. Рождественский, С. В. Глаголев, М. Ю. Фролов, А. В. Рудакова, А. В. Павлыш, Ю. Е. Балыкина, А. А. Курылёв, А. В. Иванов, Д. С. Козлов, С. Б. Васильченко, Т. И. Галимов, О. А. Логиновская, С. А. Мишинова, Т. А. Гольдина, В. А. Булатов, Е. В. Лаврентьева, В. В. Горин, Л. А. Худова, В. В. Секачёв, И. В. Ефименко, Л. И. Карпенко, А. А. Поликарова. — М.: Издательство ОКИ: Буки Веди, 2020. — 208 с.: ил. — ISBN 978-5-4465-2902-5. — https://izdatoki.ru/issledovaniya-realnoj-klinicheskoj-praktiki (In Russ).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical technologies assessment in COVID-19;HIV Infection and Immunosuppressive Disorders;2023-10-21

2. Real-world data: principles of use in decision making and in health technology assessment;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-07-19